Heska Corp (HSKA) 52.49 $HSKA Illumina Keen on
Post# of 273327
Posted On: 09/03/2016 5:20:07 AM
Heska Corp (HSKA) 52.49 $HSKA
Illumina Keen on Genome Network Growth & Global Expansion
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 2:23PM CDT
On Aug 25, 2016, we issued an updated research report on Illumina Inc. (ILMN).
HSKA: 52.49 (-0.27), ILMN: 167.90 (-0.66), ANIK: 47.89 (-0.05)
Align Technology's Invisalign Dependence: Boon or Curse?
Zacks Equity Research - Zacks Investment Research - Wed Aug 17, 5:15PM CDT
Align Technology (ALGN) ended the second-quarter 2016 on a promising note, squarely beating the Zacks Consensus Estimate.
ALGN: 95.78 (+2.02), HSKA: 52.49 (-0.27), ANIP: 59.86 (-1.56), ANIK: 47.89 (-0.05)
FDA Approves Edwards Lifesciences' Intuity Elite Heart Valve
Zacks Equity Research - Zacks Investment Research - Wed Aug 17, 5:12PM CDT
Edwards' (EW) Intuity Elite valve system is used to treat patients suffering from coronary artery disease and are required to undergo aortic valve replacement surgery.
HSKA: 52.49 (-0.27), ANIP: 59.86 (-1.56), EW: 115.85 (-0.02), ANIK: 47.89 (-0.05)
Myriad Genetics: Q4 Hit by Low Test Revenues, Gross Margin
Zacks Equity Research - Zacks Investment Research - Tue Aug 16, 7:38AM CDT
Myriad (MYGN) ended fiscal 2016 on a disappointing note, with its fourth-quarter numbers missing the Zacks Consensus Estimate on both fronts.
MYGN: 20.65 (+0.21), HSKA: 52.49 (-0.27), ANIP: 59.86 (-1.56), ANIK: 47.89 (-0.05)
MEDNAX (MD) Acquires Anesthesiology Practice in Nevada
Zacks Equity Research - Zacks Investment Research - Mon Aug 15, 9:33AM CDT
MEDNAX recently announced the acquisition of a private physician group practice -- Associated Anesthesiologists -- in Reno, Nevada.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), HSKA: 52.49 (-0.27), MD: 66.57 (+2.09)
PharMerica (PMC) Q2 Earnings in Line, Revenues Beat
Zacks Equity Research - Zacks Investment Research - Thu Aug 11, 7:16AM CDT
PharMerica reported second-quarter 2016 adjusted earnings of 47 cents per share.
PMC: 25.95 (+0.76), BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), HSKA: 52.49 (-0.27)
Heska (HSKA) Shares March Higher, Can It Continue?
Zacks Equity Research - Zacks Investment Research - Wed Aug 10, 8:56AM CDT
As of late, it has definitely been a great time to be an investor in Heska Corp (HSKA).
HSKA: 52.49 (-0.27)
BioTelemetry (BEAT) Q2 Earnings, Revenues Beat; View Up
Zacks Equity Research - Zacks Investment Research - Tue Aug 09, 8:25AM CDT
BioTelemetry Inc. reported strong second-quarter 2016 adjusted earnings of 20 cents per share.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), HSKA: 52.49 (-0.27), BEAT: 18.82 (+0.12)
Arena's (ARNA) Q2 Loss Narrower, Revenues Increase Y/Y
Arpita Dutt - Zacks Investment Research - Tue Aug 09, 6:19AM CDT
Arena (ARNA) continues to work on the advancement of its proprietary pipeline candidates.
HSKA: 52.49 (-0.27), CBM: 43.27 (+0.10), ANIP: 59.86 (-1.56), ARNA: 1.57 (+0.01)
Kite Pharma (KITE) Q2 Loss Wider but Focus is on KTE-C19
Arpita Dutt - Zacks Investment Research - Tue Aug 09, 5:44AM CDT
Although Kite's (KITE) Q2 loss was wider-than-expected, investor focus remains primarily on the company's progress with KTE-C19.
HSKA: 52.49 (-0.27), CBM: 43.27 (+0.10), KITE: 58.76 (-0.11), AMGN: 169.77 (-0.36)
Heska to Present at Canaccord Genuity 36th Annual Growth Conference on August 10, 2016
PR Newswire - Thu Aug 04, 11:00AM CDT
Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"
, a provider of advanced veterinary diagnostic and specialty products, today announced Kevin Wilson, Chief Executive Officer and President, will present at the Canaccord Genuity 36th Annual Growth Conference on Wednesday, August 10, 2016 at 4:30 p.m. ET.
HSKA: 52.49 (-0.27)
Heska Reports Record Second Quarter Results
PR Newswire - Wed Aug 03, 8:00AM CDT
Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company", a provider of advanced veterinary diagnostic and specialty products, today reported financial results for its second quarter ended June 30, 2016.
HSKA: 52.49 (-0.27)
Webcast Alert: Heska Announces Second Quarter 2016 Earnings Conference Call Webcast
PR Newswire - Tue Aug 02, 8:00AM CDT
Heska Corporation (Nasdaq: HSKA) announces the following Webcast:
HSKA: 52.49 (-0.27)
Heska (HSKA) Sees Hammer Chart Pattern: Time to Buy?
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 8:54AM CDT
Heska Corporation (HSKA) has been struggling lately, but the selling pressure may be coming to an end soon
HSKA: 52.49 (-0.27)
New Strong Buy Stocks for June 2nd
Swarup Gupta - ZACKS - Thu Jun 02, 8:30AM CDT
New Strong Buy Stocks for June 2nd
HSKA: 52.49 (-0.27), FMBH: 25.17 (+0.02), DISCA: 25.89 (+0.20), LXFR: 11.69 (+0.05), BNS: 54.33 (+0.71)
Galena Biopharma (GALE) in Focus: Stock Moves Up 19.3%
Zacks Equity Research - Zacks Investment Research - Thu Jun 02, 7:15AM CDT
Galena Biopharma, Inc. (GALE) shares rose over 19% in the last trading session.
HSKA: 52.49 (-0.27), GALE: 0.40 (unch)
Edge Therapeutics (EDGE) Catches Eye: Stock Soars 19.4%
Zacks Equity Research - Zacks Investment Research - Thu Jun 02, 7:00AM CDT
Edge Therapeutics, Inc (EDGE) was a big mover last session, as the company's shares rose over 19% on the day.
HSKA: 52.49 (-0.27), EDGE: 8.95 (-0.04)
Integra Unveils Fin-Lock Glenoid, Boosts Shoulder Arthroplasty
Zacks Equity Research - Zacks Investment Research - Tue May 24, 7:22AM CDT
Integra LifeSciences Holdings Corporation (IART) recently launched Integra Fin-Lock Glenoid.
IART: 87.17 (+0.39), HSKA: 52.49 (-0.27), ANIP: 59.86 (-1.56), NEO: 8.00 (+0.05)
Illumina Keen on Genome Network Growth & Global Expansion
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 2:23PM CDT
On Aug 25, 2016, we issued an updated research report on Illumina Inc. (ILMN).
HSKA: 52.49 (-0.27), ILMN: 167.90 (-0.66), ANIK: 47.89 (-0.05)
Align Technology's Invisalign Dependence: Boon or Curse?
Zacks Equity Research - Zacks Investment Research - Wed Aug 17, 5:15PM CDT
Align Technology (ALGN) ended the second-quarter 2016 on a promising note, squarely beating the Zacks Consensus Estimate.
ALGN: 95.78 (+2.02), HSKA: 52.49 (-0.27), ANIP: 59.86 (-1.56), ANIK: 47.89 (-0.05)
FDA Approves Edwards Lifesciences' Intuity Elite Heart Valve
Zacks Equity Research - Zacks Investment Research - Wed Aug 17, 5:12PM CDT
Edwards' (EW) Intuity Elite valve system is used to treat patients suffering from coronary artery disease and are required to undergo aortic valve replacement surgery.
HSKA: 52.49 (-0.27), ANIP: 59.86 (-1.56), EW: 115.85 (-0.02), ANIK: 47.89 (-0.05)
Myriad Genetics: Q4 Hit by Low Test Revenues, Gross Margin
Zacks Equity Research - Zacks Investment Research - Tue Aug 16, 7:38AM CDT
Myriad (MYGN) ended fiscal 2016 on a disappointing note, with its fourth-quarter numbers missing the Zacks Consensus Estimate on both fronts.
MYGN: 20.65 (+0.21), HSKA: 52.49 (-0.27), ANIP: 59.86 (-1.56), ANIK: 47.89 (-0.05)
MEDNAX (MD) Acquires Anesthesiology Practice in Nevada
Zacks Equity Research - Zacks Investment Research - Mon Aug 15, 9:33AM CDT
MEDNAX recently announced the acquisition of a private physician group practice -- Associated Anesthesiologists -- in Reno, Nevada.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), HSKA: 52.49 (-0.27), MD: 66.57 (+2.09)
PharMerica (PMC) Q2 Earnings in Line, Revenues Beat
Zacks Equity Research - Zacks Investment Research - Thu Aug 11, 7:16AM CDT
PharMerica reported second-quarter 2016 adjusted earnings of 47 cents per share.
PMC: 25.95 (+0.76), BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), HSKA: 52.49 (-0.27)
Heska (HSKA) Shares March Higher, Can It Continue?
Zacks Equity Research - Zacks Investment Research - Wed Aug 10, 8:56AM CDT
As of late, it has definitely been a great time to be an investor in Heska Corp (HSKA).
HSKA: 52.49 (-0.27)
BioTelemetry (BEAT) Q2 Earnings, Revenues Beat; View Up
Zacks Equity Research - Zacks Investment Research - Tue Aug 09, 8:25AM CDT
BioTelemetry Inc. reported strong second-quarter 2016 adjusted earnings of 20 cents per share.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), HSKA: 52.49 (-0.27), BEAT: 18.82 (+0.12)
Arena's (ARNA) Q2 Loss Narrower, Revenues Increase Y/Y
Arpita Dutt - Zacks Investment Research - Tue Aug 09, 6:19AM CDT
Arena (ARNA) continues to work on the advancement of its proprietary pipeline candidates.
HSKA: 52.49 (-0.27), CBM: 43.27 (+0.10), ANIP: 59.86 (-1.56), ARNA: 1.57 (+0.01)
Kite Pharma (KITE) Q2 Loss Wider but Focus is on KTE-C19
Arpita Dutt - Zacks Investment Research - Tue Aug 09, 5:44AM CDT
Although Kite's (KITE) Q2 loss was wider-than-expected, investor focus remains primarily on the company's progress with KTE-C19.
HSKA: 52.49 (-0.27), CBM: 43.27 (+0.10), KITE: 58.76 (-0.11), AMGN: 169.77 (-0.36)
Heska to Present at Canaccord Genuity 36th Annual Growth Conference on August 10, 2016
PR Newswire - Thu Aug 04, 11:00AM CDT
Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"
, a provider of advanced veterinary diagnostic and specialty products, today announced Kevin Wilson, Chief Executive Officer and President, will present at the Canaccord Genuity 36th Annual Growth Conference on Wednesday, August 10, 2016 at 4:30 p.m. ET. HSKA: 52.49 (-0.27)
Heska Reports Record Second Quarter Results
PR Newswire - Wed Aug 03, 8:00AM CDT
Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"
, a provider of advanced veterinary diagnostic and specialty products, today reported financial results for its second quarter ended June 30, 2016. HSKA: 52.49 (-0.27)
Webcast Alert: Heska Announces Second Quarter 2016 Earnings Conference Call Webcast
PR Newswire - Tue Aug 02, 8:00AM CDT
Heska Corporation (Nasdaq: HSKA) announces the following Webcast:
HSKA: 52.49 (-0.27)
Heska (HSKA) Sees Hammer Chart Pattern: Time to Buy?
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 8:54AM CDT
Heska Corporation (HSKA) has been struggling lately, but the selling pressure may be coming to an end soon
HSKA: 52.49 (-0.27)
New Strong Buy Stocks for June 2nd
Swarup Gupta - ZACKS - Thu Jun 02, 8:30AM CDT
New Strong Buy Stocks for June 2nd
HSKA: 52.49 (-0.27), FMBH: 25.17 (+0.02), DISCA: 25.89 (+0.20), LXFR: 11.69 (+0.05), BNS: 54.33 (+0.71)
Galena Biopharma (GALE) in Focus: Stock Moves Up 19.3%
Zacks Equity Research - Zacks Investment Research - Thu Jun 02, 7:15AM CDT
Galena Biopharma, Inc. (GALE) shares rose over 19% in the last trading session.
HSKA: 52.49 (-0.27), GALE: 0.40 (unch)
Edge Therapeutics (EDGE) Catches Eye: Stock Soars 19.4%
Zacks Equity Research - Zacks Investment Research - Thu Jun 02, 7:00AM CDT
Edge Therapeutics, Inc (EDGE) was a big mover last session, as the company's shares rose over 19% on the day.
HSKA: 52.49 (-0.27), EDGE: 8.95 (-0.04)
Integra Unveils Fin-Lock Glenoid, Boosts Shoulder Arthroplasty
Zacks Equity Research - Zacks Investment Research - Tue May 24, 7:22AM CDT
Integra LifeSciences Holdings Corporation (IART) recently launched Integra Fin-Lock Glenoid.
IART: 87.17 (+0.39), HSKA: 52.49 (-0.27), ANIP: 59.86 (-1.56), NEO: 8.00 (+0.05)
(0)
(0)